PCR Spotlight: simple guidance for the management of valvular heart disease patients in the context of COVID-19
In this video Didier Tchetche and Nicolas Dumonteil (both from Toulouse, France) discuss how to address the management of valvular heart disease patients during COVID-19.
Here are the take-home messages you should remember:
- The heart team remains at the center of decision
- Most structural procedures are going to be delayed
- Close patient follow-up is essential
- Only the more symptomatic patients are going to be treated
- Maintaining an operational interventional structural team is key
Speakers
This video was recorded on 9 April 2020.
The content of this page reflects the view of the authors at a given point in time and does not necessarily represent the view of PCR or PCRonline.
Join the discussion
Please log into your MyPCR account to add your comment
1 comment
Hello, thank you for your opinions, I agree with all your messages. My question is how you decide who is the symptomatic patient to treat? Only those comming to the hospital through the ER ? or do you call patients at home to know about their clinical state and ask them to come for "semi-elective" admission? Thank you and kind regards Flavio Ribichini